Aark Pharmaceuticals Private Limited
Breakthrough Medications Available In India
List of following breakthrough drugs for chronic diseases accessible for patients in India which has been recently launched in India. Below mentioned medicine is available in India to patients, doctors, chain pharmacy, chain hospitals, B2C pharmacies, and others. If you need an assistance or have questions for above drug please contact Aark at Email: sales@aarkpharma.co.in or give us a call at M:+91 9999156233 / (+91) 99534-66646.
Breakthrough Medicines in Glucose Monitoring Device
Breakthrough Medicines in Diabetes Treatment
Showing all 6 results
-
Erly (Liraglutide) Prefilled Pen
Read more -
Mounjaro KwikPen. In multiple-dose prefilled pen.
Read more -
Sale!
Ozempic (semaglutide) injection 0.25mg
₹8,800.00Original price was: ₹8,800.00.₹7,392.00Current price is: ₹7,392.00. Add to cart -
Rybelsus (Semaglutide) Tablets
Read more -
Soliqua Solostar (Insulin Glargine And Lixisenatide) Prefilled Pen
Read more -
Wegovy (Semaglutide) Injection
Read more
Breakthrough Medicines in Pexiform Neurofibromas Treatment - A Rare Disease.
Breakthrough Medicines in hypovolemia, hypoalbuminemia Treatment
Breakthrough Medicines in Lymphoma Treatment
Breakthrough Medicines in Leukemia Treatment
Breakthrough Medicines in Multiple Myeloma Treatment
Breakthrough Medicines in Gastrointestinal Stromal Tumor Treatment
Breakthrough Medicines in Breast Cancer Treatment
Breakthrough Medicines in Lung Cancer Treatment
Breakthrough Medicines in Prostate Cancer Treatment
Breakthrough Medicines in Colon Cancer Treatment
Breakthrough Medicines in Ovarian Cancer Treatment
Breakthrough Medicines in Kidney Cancer Treatment
Breakthrough Medicines in Liver Treatment
Breakthrough Medicines in Rheumatoid Arthritis, Osteoporosis Treatment
Breakthrough Medicines in Fungal Infection Treatment
Breakthrough Medicines in Cervical Cancer Treatment
Breakthrough Medicines in Pancreatic Cancer Treatment
Breakthrough Medicines in Esophageal Cancer Treatment
Breakthrough Medicines in Blood Thinner Treatment
Breakthrough Medicines in Respiratory Tract Disease Treatment
Breakthrough Medicines in atopic dermatitis (eczema) Disease Treatment
Mumbai Office :
9999156233
(Mrs. Himanshi)
Lucknow Office :
7065025552
(Mr. Krishna Kant)
Varanasi Office :
8010447290
(Mr. Dharmendra)
Chandigarh Office :
9876604101
(Mr Bikram)
Kolkata Office :
9810264781
(Mr Surjit)
Patna Office :
9310817125
(Mr. Chitranjan)
Jodhpur Office :
9899245300
(Mr Raju).
Contact
For any inquiries
Buy 100% authentic medicines from Aark Pharmaceuticals. Top CFA & pharma distributor supplying hospitals, clinics & patients across India. * Get the best price & exclusive discounts on all Rare Disease Medicines today! Call/WhatsApp Aark Pharmaceuticals at 9999156233 (Ms.Himansh), 98719483Chronic Diseases10 (Mr.Dheeraj) for instant availability.
Why India Is Emerging as a Hub for Leukemia Treatment
India has become a sought-after destination for advanced cancer care due to several key advantages:
Accessibility to Latest Drugs: Many global breakthrough leukemia medicines are now approved and available in India.
Cost-Effective Treatment: Compared to Western countries, the cost of leukemia treatment in India is significantly lower, making it affordable for both domestic and international patients.
Expert Oncologists & Hematologists: India is home to highly skilled doctors specializing in leukemia management.
Advanced Medical Infrastructure: Modern hospitals and cancer centers are equipped with cutting-edge technology for diagnosis and treatment.
We Have Supplied Medicines To Following Cities In India –
Disclaimer: We hereby declare that Aark Pharmaceuticals exclusively exports biosimilars or generic medicines manufactured in India. We do not export products manufactured by multinational companies. Our commitment lies in offering cost-effective healthcare solutions through generic medications, ensuring accessibility and affordability for all our customers. For any inquiries or assistance regarding our product range, please feel free to contact us.















































































